Semin Thromb Hemost 2000; Volume 26(Number 01): 011-016
DOI: 10.1055/s-2000-9796
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4663

Studies on Congenital Protein C Deficiency in Japanese: Prevalence, Genetic Analysis, and Relevance to the Onset of Arterial Occlusive Diseases

Toshiyuki Sakata1 , Kazuomi Kario3 , Yoshiaki Katayama1 , Tatsuo Matsuyama1 , Hisao Kato2 , Toshiyuki Miyata2
  • 1Laboratory of Clinical Chemistry, National Cardiovascular Center, Osaka, Japan and
  • 3Research Institute, National Cardiovascular Center, Osaka, Japan and the
  • 2Department of Cardiology, Jichi Medical School, Tochigi, Japan
Further Information

Publication History

Publication Date:
31 December 2000 (online)

 

ABSTRACT

Hereditary protein C deficiency is associated with a predisposition to venous thrombosis. We identified 43 patients with protein C deficiency by screening approximately 26,800 patients admitted to the National Cardiovascular Center Hospital. The observed prevalence of protein C deficiency was 1 per 620. We performed genetic analyses of 57 Japanese families with protein C deficiency. Combined with the results of the other studies in 10 families, the 67 Japanese families with protein C deficiency have been examined and 39 different gene defects have been identified. Some changes were solely identified in Japanese subjects, whereas others showed no such ethnic bias. The recurrent defects of Phe139Val, Arg169Trp, Val297Met, and Met364Ile substitutions and a G8857 deletion were found in 33 Japanese families, accounting for 49% of Japanese families with protein C deficiency, Finally, we examined the relevance of protein C deficiency to the onset of arterial occlusive diseases. In the examination of whether protein C deficiency hastens arterial occlusion, we found a significant difference (p = 0.02) in the age at onset of acute myocardial infarction between the patients with protein C deficiency (n = 10: 49.4 ± 14.8 years) and a group of patients with normal protein C levels (n = 42: 60.5 ± 10.6 years). At the onset of atherothrombotic cerebral infarction, the patients with protein C deficiency were significantly (p = 0.022) younger (n = 11:57.4 ± 12.8 years) than those with normal protein C levels (n = 48: 64.6 ± 10.1 years). Thus, we conclude that congenital protein C deficiency hastens the onset of arterial occlusive diseases, especially acute myocardial infarction, in Japanese subjects.

KEYWORD

Protein C deficiency - prevalence - genetic analysis - arterial occlusion - acute myocardial infarction

REFERENCES

  • 1 Esmon C T. The roles of protein C and thrombomodulin in the regulation of blood coagulation.  J Biol Chem . 1989;  264 4743-4746
    PubMedGoogle Scholar
  • 2 Stearns-Kurosawa D J, Kurosawa S, Mollica J S, Ferrell G L, Esmon C T. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.  Proc Natl Acad Sci USA . 1996;  93 10212-10216
    CrossrefPubMedGoogle Scholar
  • 3 Lane D A, Mannucci P M, Bauer K A. Inherited thrombophilia. Part 1.  Thromb Haemost . 1996;  76 651-662
    PubMedGoogle Scholar
  • 4 De Stefano V, Finazzi G, Mannucci P M. Inherited thrombophilia: pathogenesis, clinical syndromes, and management.  Blood . 1996;  87 3531-3544
    PubMedGoogle Scholar
  • 5 Miletich J, Sherman L, Broze Jr G. Absence of thrombosis in subjects with heterozygous protein C deficiency.  N Engl J Med . 1987;  17 991-996
    PubMedGoogle Scholar
  • 6 Tait R C, Isobel D, Walker I D. Prevalence of protein C deficiency in the healthy population.  Thromb Haemost . 1995;  73 87-93
    PubMedGoogle Scholar
  • 7 Miyata T, Zheng Y Z, Sakata T, Tsushima N, Kato H. Three missense mutations in the protein C heavy chain causing type I and type II protein C deficiency.  Thromb Haemost . 1994;  71 32-37
    PubMedGoogle Scholar
  • 8 Zheng Y Z, Sakata T, Matsusue T. Six missense mutations associated with type I and type II protein C deficiency and implications obtained from molecular modelling.  Blood Coag Fibrinolysis . 1994;  5 687-696
    PubMedGoogle Scholar
  • 9 Miyata T, Zheng Y Z, Sakata T, Kato H. Protein C Osaka 10 with aberrant propeptide processing: Loss of anticoagulant activity due to an amino acid substitution in the protein C precursor.  Thromb Haemost . 1995;  74 1003-1008
    PubMedGoogle Scholar
  • 10 Miyata T, Sakata T, Zheng Y Z. Genetic characterization of protein C deficiency in Japanese subjects using a rapid and nonradioactive method for single-strand conformational polymorphism analysis and a model building.  Thromb Haemost . 1996;  76 302-311.
    PubMedGoogle Scholar
  • 11 Miyata T, Sakata T, Yasumuro Y. Genetic analysis of 19 Japanese protein C deficiency: 5 recurrent defects can explain half of Japanese protein C deficiency.  Thromb Res . 1999;  92 181-187
    PubMedGoogle Scholar
  • 12 Reitsma P H, Bernardi F, Doig R G. Protein C deficiency: A database of mutations, 1995 update.  Thromb Haemost . 1995;  73 876-889
    PubMedGoogle Scholar
  • 13 Tokunaga F, Wabayashi S, Saito H. Identification of one base deletion in exon IX of the protein C gene that causes a type I deficiency.  Thromb Res . 1992;  68 417-423
    CrossrefPubMedGoogle Scholar
  • 14 Kohler J, Kasper J, Witt I, von Reutern G-M. Ischemic stroke due to protein C deficiency.  Stroke . 1990;  21 1077-1080
    CrossrefPubMedGoogle Scholar
  • 15 De Stefano V, Leone G, Micalizzi P. Arterial thrombosis as clinical manifestation of congenital protein C deficiency.  Ann Hematol . 1991;  62 180-183
    CrossrefPubMedGoogle Scholar
  • 16 Kario K, Matsuo T, Tai S. Congenital protein C deficiency and myocardial infarction: Concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis.  Thromb Res . 1992;  67 95-103
    CrossrefPubMedGoogle Scholar
  • 17 Sakata T, Kazui S, Morishita T. A case of arterial cerebral thrombosis with congenital protein C deficiency.  Jpn J Thromb Haemost . 1992;  3 185-190
    PubMedGoogle Scholar
  • 18 Kazui S, Kuriyama Y, Sakata T. Accelerated brain infarction in hypertension complicated by hereditary heterozygous protein C deficiency.  Stroke . 1993;  24 2097-2103
    PubMedGoogle Scholar
  • 19 De Stefano V, Leone G, Mastrangelo S. Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S.  Thromb Haemost . 1994;  72 352-358
    PubMedGoogle Scholar
  • 20 Sakata T, Goto Y, Kario K. Recurrent restenosis after percutaneous transluminal coronary angioplasty in a patient with congenital protein C deficiency and high activated factor VII level.  Thromb Res . 1996;  81 687-691
    CrossrefPubMedGoogle Scholar
  • 21 Sakata T, Kario K, Katayama Y. Analysis of 45 episodes of arterial occlusive disease in Japanese patients with congenital protein C deficiency.  Throm Res . 1999;  94 69-78
    PubMedGoogle Scholar
  • 22 Gladson C L, Scharrer I, Hach V, Beck K H, Griffin J H. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.  Thromb Haemost . 1988;  59 18-22
    PubMedGoogle Scholar
  • 23 Horellou M H, Conard J, Bertina R M, Samama M. Congenital protein C deficiency and thrombotic disease in nine French families.  Br Med J . 1984;  289 1285-1287
    PubMedGoogle Scholar
  • 24 Smirnov M D, Pyzh M V, Borovikov D V. Low doses of activated protein C delay arterial thrombosis in rats.  Thromb Res . 1990;  57 645-650
    CrossrefPubMedGoogle Scholar
  • 25 Gruber A, Hanson S R, Kelly A B. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis.  Circulation . 1990;  82 578-585
    PubMedGoogle Scholar
  • 26 Arnljots B, Dahlbäck B. Antithrombotic effects of activated protein C and protein S in a rabbit model of microarterial thrombosis.  Arterioscler Thromb Vasc Biol . 1995;  15 937-941
    PubMedGoogle Scholar
      >